Cardiovascular and Circulatory System Hypertension

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Hypertension Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Hypertension Projects
--DAIICHI SANKYO COMPANY, LIMITED
--Bristol-Myers Squibb Company
--Encysive Pharmaceuticals Inc
--Dr Reddys Laboratories Ltd
--Gilead Sciences Inc
--Forest Laboratories Inc
--Merck & Co Inc
--Menarini Group
--Par Pharmaceutical Companies Inc
--Novartis AG
--Ranbaxy Laboratories Ltd.
--Protherics PLC
--Shionogi & Co., Ltd.
--RECORDATI SpA
--Solvay S.A.
--Sigma-Tau S.p.A.
--Surface Logix, Inc.
--Speedel
--Teva Pharmaceutical Industries Ltd
--Takeda Pharmaceutical Company Limited

--Top Companies in early stage Hypertension Projects
--BioLineRx, Ltd.
--Arete Therapeutics Inc.
--Cary Pharmaceuticals Inc.
--Biovail Corporation
--DAIICHI SANKYO COMPANY, LIMITED
--Daewoong Pharmaceutical Co. Ltd.
--Exelixis Inc
--Dov Pharmaceutical Inc
--Merck & Co Inc
--IntelGenx Technologies Corp.
--Novartis AG
--NicOx S.A.
--Pfizer Inc
--Novavax Inc
--Sanofi-Aventis
--Rottapharm SpA
--Takeda Pharmaceutical Company Limited
--Speedel
--Vitae Pharmaceuticals, Inc.
--erly Concurrent Pharmaceuticals)
--Torrent Pharmaceuticals Limited

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View